Unknown PHASE2 INTERVENTIONAL 4-arm NCT03963882

NAC Followed by RH for the Treatment of LACC

Neoadjuvant Chemotherapy Followed by Radical Hysterectomy for the Treatment of Locally Advanced Cervical Cancer: A Prospective Cohort Study

Sponsor: Lei Li

Conditions Adjuvant Therapy Concurrent Chemoradiotherapy Laparoscopy Laparotomy Locally Advanced Cervical Cancer Neoadjuvant Chemotherapy Objective Response Radical Hysterectomy Systematic Chemotherapy

Interventions First imaging evaluation Pathologic evaluation RH Radiochemotherapy Second imaging evaluation The third cycles of neoadjuvant chemotherapy Two cycles of neoadjuvant chemotherapy

Updated 6 times since 2019 Last updated: Jun 19, 2019 Started: Jun 19, 2019 Primary completion: Jun 1, 2024 Completion: Jun 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Adjuvant Therapy and Concurrent Chemoradiotherapy and is currently ongoing. Lei Li leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Jul 2025 — Present [monthly]

Unknown PHASE2

Status: Recruiting → Unknown
Sep 2024 — Jul 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jan 2021 — Jul 2024 [monthly]

Recruiting PHASE2
Jul 2019 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jun 2019 — Jul 2019 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lei Li

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China